Although our model system has caveats associated with overexpression (i.e., high levels of CBFB::MYH11 may affect its intracellular distribution), we orthogonally validated these findings using primary human AML samples with physiologic CBFB::MYH11 expression. This evidence concerns the gene MYH11 and acute myeloid leukemia.